Commit To Purchase Mirati Therapeutics At $95, Earn 17% Annualized Using Options
August 20, 2021 at 11:45 AM EDT
Investors considering a purchase of Mirati Therapeutics Inc (MRTX) stock, but tentative about paying the going market price of $134.96/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2022 put at the $95 strike, which has a bid at the time of this writing of $6.80..